Julia Wiedmeier-Nutor

8PUBLICATIONS
50CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Mar 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.

Gayle S Jameson, Denise J Roe, Erkut Borazanci

|Jun 10, 2025
Hyperdiploid myeloma: The silent majority.

J Erin Wiedmeier-Nutor, Rafael Fonseca

|Jul 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations.

J Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien

|Apr 18, 2022
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T.

Julia Wiedmeier-Nutor, Jose Leis

Pageof 2

Frequent Collaborators

2 joint publications

Kenneth Jc Lim

2 joint publications

Melinda Tan

2 joint publications

Saurabh Chhabra

2 joint publications

Morie Gertz